Searchable abstracts of presentations at key conferences in endocrinology

ea0025p53 | Clinical biochemistry | SFEBES2011

Echocardiogram in prolactinoma patients taking ergot derived dopamine agonists

Naziat Auditi , Elsheikh Mohgah

Background: The use of high dose Ergot derived dopamine agonists in patients with Parkinson’s disease has been associated with an increased risk of cardiac valvular fibrosis. The UK Medicines and Health products Regulatory Agency (MHRA) currently advises baseline Echocardiogram within 3–6 months and follow up Echocardiogram at 6–12 monthly intervals in all patients taking ergot derived dopamine agonists. However, the risk of cardiac valvulopathy with lower doses...

ea0025p316 | Thyroid | SFEBES2011

The mystery of persistent thyrotoxicosis

Naziat Auditi , Elsheikh Mohgah , Kingston Gearoid

We report an unusual case of struma ovarii diagnosed after thyroidectomy for Graves’ disease and papillary thyroid cancer.A 46-year-old woman presented with a 3-month history of weight loss, palpitations and irregular periods. Physical examination revealed tachycardia, fine tremor and a diffuse goitre. TSH <0.1 (0.5–4.2 mU/l), FreeT4 26 (10.8–19.3 pmol/l) confirmed thyrotoxicosis.Thyroid ultrasound scan showed a ...

ea0065p27 | Adrenal and Cardiovascular | SFEBES2019

Secondary hypertension service in a District General Hospital – the success story

Naziat Auditi , Banerjee Ritwik , Dhere Archana , Soo Shiu-Ching

A secondary hypertension service was set up by the Endocrinology team in 2016 aiming to capture young hypertensive (age <30 years), refractory hypertension and hypertensive emergency to provide holistic care. A pathway was developed streaming Hypertensive emergencies to the high dependency area for intravenous treatment and hypertensive urgencies to the Ambulatory care for oral medications. All patients were linked to a secondary hypertension clinic. Staring with one clini...

ea0021p163 | Diabetes and metabolism | SFEBES2009

An exploration of the predictive factors for the early pleiotropic responses to exenatide therapy in patients with type 2 diabetes mellitus

Barber Thomas , Reddy Narendra , Begbie Helen , Sophal Naseem , McCulloch Carol , Rogers Angela , Naziat Auditi , Ghosh Diptendra , Mukhtar Mamoun , Simpson Hugh

Aims: Our aim was to explore predictive factors for the pleiotropic responses to exenatide during the first 12 weeks of therapy, and associations between these responses.Methods: This was an observational study based on patients (n=83) with type 2 diabetes mellitus (T2D) in whom exenatide had been added to existing oral hypoglycaemic therapy. Exenatide was administered subcutaneously (5 mcg bd for the first month, 10 mcg bd thereafter). Data colle...

ea0074ncc9 | Highlighted Cases | SFENCC2021

A rare case of Hypocalcaemia – A diagnostic dilemma

Abeyaratne Dayakshi , Healy Ultan , Naziat Auditi , Tomlinson Jeremy , Pal Aparna , Hannan Fadil , Thakker Rajesh , Shine Brian , Jafar-Mohammadi Bahram

Case history: A 38-year-old woman presented with blepharospasm, cramping of the hands, and paraesthesia primarily affecting the face and hands. Symptoms had been present for 10 years but had been progressive over the previous 12 months. Symptoms were consistent with neuromuscular instability. Hypocalcaemia and elevated Parathyroid hormone (PTH) were confirmed. Past medical history was notable for anorexia nervosa in remission. Family history was non-contributary. Hypocalcaemia...